In recent months, states have increasingly introduced proposals for individuals above Medicaid eligibility levels to “buy-in” to Medicaid or leverage the Medicaid program to strengthen coverage across the individual market and Medicaid. State Health and Value Strategies is tracking current state activity and has mapped out which states are pursuing a program and those that are establishing task forces to understand the impact of a Medicaid buy-in program.
The SUPPORT Act: New Tools in Medicaid to Address the Opioid Epidemic
Every day, an average of more than 115 Americans die from an opioid overdose, reflecting a crisis that has evolved – but not dissipated. Following several months of bipartisan, bicameral hearings, markups, and negotiations about how to address the opioid epidemic, the Senate on October 3 passed H.R. 6, The Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (the “SUPPORT Act”). On October 25, President Trump signed the legislation. On November 16, State Health and Value Strategies hosted a webinar, with technical experts from Manatt Health, on the SUPPORT Act. Most stakeholders agree that the bill is a significant step forward in addressing the opioid epidemic, reflecting a range of important policy changes such as initiatives to increase access to medication-assisted treatment (MAT), new grant, pilot and demonstration projects, and a series of changes to Medicaid and Medicare. During this webinar, experts from Manatt Health reviewed major health provisions of the new law and implications for states.